Tag Archives: Abbvie

Novartis v. Breckenridge: Obviousness-Type Double Patenting Explained

Without trying to summarize this well-written opinion by Judge Chen, I simply recommend that you store it somewhere and pull it out when you have a tricky obviousness-type double-patenting situation and want a thorough review of the doctrine. The opinion … Continue reading

Posted in Double Patenting, Obviousness | Tagged , , , , , | Leave a comment

Abbvie V. Janssen Biotech –Written Description Requirement Road Map

The recent decision in Abbvie Deutschland v. Janssen Biotech and Centorcor Biologics, App. No. 2013-1338, -1346 (Fed. Cir. , July 1, 2014) deserves more attention than it has received. (A copy of the decision is available at the end of … Continue reading

Posted in Written Description Requirements (WDR) | Tagged , , , , , , , , , | 1 Comment